亚太地区辐射剂量管理市场预测至 2028 年 - 按服务/软件（辐射剂量管理服务和辐射剂量管理软件）、媒介（计算机断层扫描、辐射和乳房 X 线摄影、透视和乳房 X 线摄影以及其他媒介）的 COVID-19 影响和区域分析）和最终用户（医院、研究和医疗机构等）
No. of Pages: 153 | Report Code: TIPRE00029193 | Category: Life Sciences
No. of Pages: 153 | Report Code: TIPRE00029193 | Category: Life Sciences
市场的增长是由于不断增长重点关注介入放射学和核医学以及需要放射治疗的癌症病例的增加。然而，组织挑战和缺乏剂量优化基准预计将限制预测期内的市场增长。
医疗技术、设备制造和成像设备的快速发展已经结果是用更好的技术改进了原始程序，并扩大了程序的适应症。新技术已经被开发出来，并且一些技术被迁移到其他成像模式。全球范围内开展了越来越多的介入放射学和核医学手术，成像效率很高。这些手术使用高剂量的辐射，较长的持续时间可能会增加接受这些手术的患者患癌症的风险。
据世界核协会报告，超过 10,000 家医院全球范围内在医学中使用放射性同位素，90% 的放射性同位素程序用于诊断。
拜耳医疗保健 (Bayer Healthcare) 和 Sectra Medical Systems 等市场参与者提供专门用于介入治疗中 RDM 的剂量管理软件影像学和核医学。尽管 CT 应用在辐射剂量管理市场中占据较大份额，但介入放射学和核医学应用预计将在不久的将来提供显着的增长机会。
亚太地区辐射剂量管理市场按服务或软件分为辐射剂量管理服务和辐射剂量管理软件。亚太地区辐射剂量管理市场按介质细分为计算机断层扫描、辐射和乳房X光检查、透视和乳房X光检查以及其他介质。根据最终用户，亚太地区辐射剂量管理市场分为医院、研究和医疗机构等。从地域上看，亚太地区辐射剂量管理市场可分为 中国、日本、印度、韩国、澳大利亚和亚太其他地区。
FUJIFILM Holdings Corporation、Bayer AG、Bracco Imaging SpA、GE Healthcare、Koninklijke Philips NV、Medsquare、Novarad Corporation、Sectra AB 和 PACSHealth, LLC 都是在亚太地区运营的领先公司辐射剂量管理市场。
Strategic insights for Asia Pacific Radiation Dose Management involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 35.57 Million |
| Market Size by 2028 | US$ 82.09 Million |
| Global CAGR (2021 - 2028) | 12.7% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 服务/软件
|
| Regions and Countries Covered | 亚太地区
|
| Market leaders and key company profiles |
The regional scope of Asia Pacific Radiation Dose Management refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Radiation Dose Management Market is valued at US$ 35.57 Million in 2021, it is projected to reach US$ 82.09 Million by 2028.
As per our report Asia Pacific Radiation Dose Management Market, the market size is valued at US$ 35.57 Million in 2021, projecting it to reach US$ 82.09 Million by 2028. This translates to a CAGR of approximately 12.7% during the forecast period.
The Asia Pacific Radiation Dose Management Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Radiation Dose Management Market report:
The Asia Pacific Radiation Dose Management Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Radiation Dose Management Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Radiation Dose Management Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Radiation Dose Management Market
